← Open Payments lookup

DIPAL DIVECHA: Open Payments

NPI 1023351384 · SUGARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$11,839 in 232 payments from 33 companies in 2025. Trend: 2023 $860 · 2024 $1,183 · 2025 $11,839

Speaker / faculty: $7,403Food & beverage: $4,436
CompanyPaymentsAmount
Insulet Corporation26$7,820
Amgen Inc.29$567
Novo Nordisk Inc28$521
Ascendis Pharma Endocrinology Inc11$397
Corcept Therapeutics12$266
BETA BIONICS, INC.9$237
Lilly USA, LLC14$220
Tandem Diabetes Care, Inc.8$210
Dexcom, Inc.20$209
Bayer Healthcare Pharmaceuticals Inc.11$159

Products named: Omnipod, Yorvipath, JARDIANCE, Korlym, Wegovy, TEPEZZA, iLet Bionic Pancreas, Ozempic.

Industry payments across TX — which companies pay providers there.